In mice treated with MPTP to assimilate PD, the inhibition of CI activity with a concomitant increase in glutaredoxin activity in the brain was observed, and this was followed by the damage inflicted upon selective dopaminergic neurons. The gene discussed is GLRX; the disease is Parkinson disease.